Privigen 10% vial 400ML
Ended Awarded
- Contract number
- SPE2DR26FHNP2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,816
Award facts
- Contract value 100% obligated
- $69,816.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,816 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PRIVIGEN 10% Vial 400ML. The delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499,999,999 ceiling value and extends through December 31, 2036.
The PPV-G GEN V represents part of the broader $30.3 billion Department of Defense pharmaceutical supply strategy, authorizing the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders and its extensive product portfolio—spanning branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals—positions it as a critical supplier within the federal military medical system's pharmaceutical supply chain. The company maintains no identified subcontractor relationships in its federal contracting activities.
Quick answers
Who was awarded contract SPE2DR26FHNP2?
SPE2DR26FHNP2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DR26FHNP2 worth?
The government has obligated $69,816 on SPE2DR26FHNP2.
Is contract SPE2DR26FHNP2 an order under another contract?
Yes. SPE2DR26FHNP2 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNP2 competed?
The extent of competition for SPE2DR26FHNP2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award